These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 16785999)
1. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms. Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713 [TBL] [Abstract][Full Text] [Related]
3. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946 [TBL] [Abstract][Full Text] [Related]
4. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056 [TBL] [Abstract][Full Text] [Related]
5. Detection of activated ras oncogenes in human thyroid carcinomas. Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656 [TBL] [Abstract][Full Text] [Related]
6. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter. Santelli G; de Franciscis V; Portella G; Chiappetta G; D'Alessio A; Califano D; Rosati R; Mineo A; Monaco C; Manzo G Cancer Res; 1993 Nov; 53(22):5523-7. PubMed ID: 8221693 [TBL] [Abstract][Full Text] [Related]
7. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985 [TBL] [Abstract][Full Text] [Related]
8. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin. Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266 [TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant. Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981 [TBL] [Abstract][Full Text] [Related]
10. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Challeton C; Bounacer A; Du Villard JA; Caillou B; De Vathaire F; Monier R; Schlumberger M; Suárez HG Oncogene; 1995 Aug; 11(3):601-3. PubMed ID: 7630645 [TBL] [Abstract][Full Text] [Related]
11. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study. Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954 [TBL] [Abstract][Full Text] [Related]
12. Activated ras oncogenes in human thyroid cancers. Lemoine NR; Mayall ES; Wyllie FS; Farr CJ; Hughes D; Padua RA; Thurston V; Williams ED; Wynford-Thomas D Cancer Res; 1988 Aug; 48(16):4459-63. PubMed ID: 3293774 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030 [TBL] [Abstract][Full Text] [Related]
16. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. Gui K Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739 [TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of follicular cell derived thyroid cancers. Parameswaran R; Brooks S; Sadler GP Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316 [TBL] [Abstract][Full Text] [Related]
18. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253 [TBL] [Abstract][Full Text] [Related]
19. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours. Banito A; Pinto AE; Espadinha C; Marques AR; Leite V Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453 [TBL] [Abstract][Full Text] [Related]
20. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]